About Us
Corporate Overview
Executive Leadership
Management team
Scientific Advisory Board
Board of Directors
Product Portfolio
Pipeline
Overview
AG-86893
AG-80308
AG-73305
Disease
Overview
DME
wAMD
Other Diseases
Pterygium
Dry Eye
Investor Relations
Investors
Press Release & Publications
Contact Us
News
2021-09-03
Allgenesis Biotherapeutics and AffaMed Therapeutics Announce License Agreement for AG-73305 in Greater China Region
Read more
2021-07-15
Allgenesis announces the appointment of Dr. Sunil Patel as Chief Medical Officer
Read more
2020-06-22
Allgenesis Receives Notice of Grant for AG-86893 in Korea and Japan for the Treatment of Pterygium
Read more
2020-06-08
Allgenesis Receives Notices of Grant of European, Japanese and Taiwan Patent for AG-73305, a Fusion Protein of VEGF Trap and Disintegrin
Read more
2020-05-22
Allgenesis Signs Deal to In-License a Clinical Stage Drug Candidate for Dry Eye Disease
Read more
